Show simple item record

dc.contributor.authorMwachari, C
dc.contributor.authorNduba, V
dc.contributor.authorNguti, R
dc.contributor.authorPark, DR
dc.contributor.authorSanguli, L
dc.contributor.authorCohen, CR
dc.date.accessioned2015-09-21T05:19:28Z
dc.date.available2015-09-21T05:19:28Z
dc.date.issued2007
dc.identifier.citationINT J TUBERC LUNG DIS 11(11):1253–1259en_US
dc.identifier.urihttp://www.ingentaconnect.com/content/iuatld/ijtld/2007/00000011/00000011/art00017?crawler=true
dc.identifier.urihttp://hdl.handle.net/11295/91212
dc.description.abstractABSS had small floor and ceiling effects (1.8/0.2) and demonstrated high internal consistency (coefficient of 0.66) and internal validity, with a mean inter item total correlation of 0.25. Effect sizes from baseline to subsequent follow-up visits were large (0.5). Wheezing and chest pain were associated with higher ABSS values, whereas irrelevant clinical variables were not. CONCLUSION: The ABSS demonstrated good responsiveness, high internal consistency, good correlation with common respiratory signs and symptoms and high discriminatory validity among patients with acute bronchitis in a high HIV-seroprevalence setting.en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.subjectoutcome assessment; severity of illness index; sub-Saharan Africa; HIV; questionnaires; acute bronchitis severity score (ABSSen_US
dc.titleValidation of a new clinical scoring system for acute bronchitisen_US
dc.typeArticleen_US
dc.type.materialen_USen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record